Auris Health, Inc. Stock

Robotic endoscopy medical device company

Sign up today and learn more about Auris Health, Inc. Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.



Notable Investors

Highland Capital Partners


San Carlos CA, US

Total Funding


About Auris Health, Inc. Stock

Auris Health develops robotics technology for endoscopy - a nonsurgical medical procedure used to examine a person's digestive tract. The Company currently has one offering: Monarch Platform. The Monarch Platform and its accessories are intended to provide bronchoscopic visualization of and access to patient airways for diagnostic and therapeutic procedures. According to the company, its Monarch Platform improves upon existing minimally invasive techniques by integrating robotics, micro-instrumentation, endoscope design, sensing, and data science into one platform to enable new categories of care. The Company states that lung cancer is the first disease it is targeting.

Auris had been in "stealth" for nearly a decade, but in March 2018, it attained FDA approval for its Monarch Platform to be used for "bronchoscopic procedures," such as diagnosing lung cancer.

The Company was incorporated in 2007 and is based in the San Francisco Bay area.

Bronchoscopy Overview:

Source: Crunchbase; Auris


Funding History

May 2009$1.6M
June 2011$9.7M
August 2012$1.4M
March 2014$33.0M
September 2015$208M
June 2017$280M
November 2018$220M


Co-Founder & CEO

Fred Moll

Chief Strategy Officer

Josh DeFonzo


David Styka

VP of Operations

Dan Bradford

VP of Sales

Eric Davidson

VP of Engineering

Richard Leparmentier

VP of R&D

David Mintz

VP of Business Development

David Schummers


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: